Health Catalyst (HCAT): Director sold ~$31K

~$31K

Approx. value · 4,500 sh @ $6.93

70K

Holds after · shares reported

Traded

Dec 30, 2024

Filed

Jan 2, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Nov 5, 2024InsiderOfficer sold ~$40K of HCAT shares in the open market
2. Nov 15, 2024InsiderOfficer sold ~$12K of HCAT shares in the open market
3. Dec 2, 2024InsiderOfficer sold ~$67K of HCAT shares in the open market
4. Dec 4, 2024InsiderOfficer sold ~$175K of HCAT shares in the open market
5. Dec 6, 2024Insider · 2 peopleInsiders: 2 sales (~$323K)
6. Dec 16, 2024InsiderOfficer sold ~$51K of HCAT shares in the open market
7. Dec 23, 2024InsiderDirector sold ~$31K of HCAT shares in the open market
8. Dec 30, 2024 · this disclosureInsiderDirector sold ~$31K of HCAT shares in the open market

What came next

1. Jan 6, 2025Insider · 2 peopleInsiders: 2 sales (~$58K)
2. Jan 15, 2025InsiderOfficer sold ~$37K of HCAT shares in the open market
3. Feb 5, 2025InsiderOfficer sold ~$30K of HCAT shares in the open market
4. Feb 18, 2025InsiderOfficer sold ~$35K of HCAT shares in the open market
5. Mar 5, 2025InsiderOfficer sold ~$76K of HCAT shares in the open market
6. Mar 6, 2025InsiderOfficer sold ~$63K of HCAT shares in the open market
7. Apr 3, 2025InsiderOfficer sold ~$22K of HCAT shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Health Catalyst

For Health Catalyst, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HCAT page.

Other recent filings by Duncan Gallagher, Director

• SEC Form 4 at Health Catalyst (HCAT)Dec 27, 2024

The full history of Duncan Gallagher, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Health Catalyst

• SEC Form 4Nov 13, 2026
• SEC Form 4Nov 13, 2026
• SEC Form 144Nov 12, 2026
• SEC Form 144Nov 11, 2026
• SEC Form 4Sep 17, 2026
• SEC Form 4Dec 10, 2025

Everything OQRO holds on this company is on its HCAT page.